Searched for
EPIRUS SWITZERLAND GMBH
Ranbaxy narrows Q4 loss on US acne drug salesPharma major Ranbaxy Laboratories today reported a drastic drop in net loss at Rs 158.48 crore during the fourth quarter ended December 31,...- Ranbaxy enters into licensing pact with EPIRUS SwitzerlandRanbaxy Laboratories have entered into a licensing pact with EPIRUS Switzerland GmbH for treating rheumatoid arthiritis.
- Load More